Conditions attached to Dutch government investments in corona vaccines and medication to guarantee affordability and accessibility are are insufficient at best and, at worst, counterproductive. Vaccine manufacturing companies are able to negotiate conditions into the financing agreements that relieve them of any responsibility if something goes wrong.
How can we make publicly funded corona vaccines accessible to all?
This is what SOMO and Wemos have revealed through research into the investment contracts between the Dutch government and companies corona vaccine development.
Sign up
Stay up-to-date with SOMOs Newsletter
